Since 2004, Dr. Scott M. Rocklage has been one of the managing partners at 5AM Venture Management, LLC. 2003 is when Dr. Rocklage had joined the 5 AM ventures team as a Venture Partner. From May 11, 2016 till July 25, 2016 he served at EPIRUS Biopharmaceuticals, Inc as the Chief Executive Officer. Then Dr. Rocklage was able to serve at Amersham Health as the Chief Executive Officer and the President. Read more: Scott Racklage | Bloomberg and Scott Racklage | Crunchbase
From July 1994 until June of 2003 he was able to serve as Cubist Pharmaceuticals Founding Chief Executive Officer. Dr. Scott Rocklage is found as being one busy man. Until June 19, 2014 he was able to serve as the chairman on the Board of Semprus Biosciences Corp. He was then able to serve as being the chairman of Cubist Pharmaceuticals Inc, he served that position from March 2000 until December 31 of 2004.
From March 2006 till March 13, 2017 Dr.Rocklage served his position as Director of Pulmatrix, Inc. His list of achievements does not stop there though. He went on to serve at Miikana Thrapeutics, Inc. and Semprus as the Executive Chairman. Then from July 15, 2014 till July 25, 2016, Dr. Rocklage served as the Director at EPIRUS Biopharmaceuticals, Inc.
Dr. Rocklage is known for having tons of experience in healthcare management, strategic leadership track record and a scientific background. He recieved, from the Massachusetts Institute of Technology, his Ph.D. in chemistry.
He was also able to conduct research on the Nobel Prize winner Richard R. Schrock. Dr. Rocklage finally received, from the University of California, his B.S in Chemistry. It is safe to say that Dr. Rocklage is a very succesful business man, that is planning on achieving more and more as he goes.
Learn more about Scott Rocklage: http://www.thestylemaponline.com/the-amazing-career-of-scott-rocklage-of-5am-ventures/